Clinical Trials Insight: 700032402
Phase of Trial: Phase I
Latest Information Update: 14 Jul 2010
At a glance
- Drugs Nerve growth factor (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors NsGene
- 14 Jul 2010 Preliminary results from this trial have been reported at the 2010 International Conference on Alzheimer's Disease.
- 10 Apr 2008 New trial record.